Platelet-Active drugs: The relationships among dose, effectiveness, and side effects

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 470S-488S

  Patrono, Carlo ^a   Coller, Barry ^a   Dalen, James E ^a   Fuster, Valentin ^a   Gent, Michael ^a   Harker, Laurence A ^a   Hirsli, Jack ^a   Roth, Gerald ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLOROPHENYL) 2 (4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDIN 5 YL)ACETIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; DRUG METABOLITE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; INDOBUFEN; LAMIFIBAN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFINPYRAZONE; THIENO[2,3 B]PYRIDINE DERIVATIVE; THROMBOXANE A2; TICLOPIDINE; TIROFIBAN; TRIFLUSAL; UNCLASSIFIED DRUG;

ANTICOAGULATION; BLEEDING; BLOOD TOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM;

EID: 0031760604     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Hirsh J, Dalen JE, Fuster V, et al. Aspirin and other platelet-active drugs: the relationship among dose, effectiveness and side effects. Chest 1995; 108(suppl):247S-257S
2. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 1997; 349:1569-1581
3. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997; 349:1641-1649